Optimising weight-loss interventions in cancer patients—A systematic review and network meta-analysis
LeVasseur N, Cheng W, Mazzarello S, Clemons M, Vandermeer L, Jones L, Joy AA, Barbeau P, Wolfe D, Ahmadzai N, Hersi M, Stober C, Shorr R, Hilton J, Hutton B. Optimising weight-loss interventions in cancer patients—A systematic review and network meta-analysis. PLOS ONE 2021, 16: e0245794. PMID: 33539414, PMCID: PMC7861370, DOI: 10.1371/journal.pone.0245794.Peer-Reviewed Original ResearchConceptsBody mass indexStandard careCancer patientsDietary interventionAnthropometric measuresLifestyle interventionWaist circumferenceWeight lossSystematic reviewCochrane Trial RegistryEffective lifestyle interventionsGreater BMI reductionMedian intervention durationOptimal lifestyle interventionCombination strategiesAdult cancer patientsWeight loss interventionEffects of exerciseEarly-stage cancerOutcomes of interestMore weight lossBMI reductionAdult patientsExercise interventionTrials RegistryNumber needed to treat in indirect treatment comparison
Guyot P, Cheng W, Tremblay G, Copher R, Burnett H, Li X, Makin C. Number needed to treat in indirect treatment comparison. Journal Of Comparative Effectiveness Research 2018, 7: 259-269. PMID: 29537878, DOI: 10.2217/cer-2017-0023.Peer-Reviewed Original ResearchConceptsRR-DTC patientsIndirect treatment comparisonIndirect comparisonRadioiodine-refractory differentiated thyroid cancer patientsDifferentiated thyroid cancer patientsTreatment comparisonsThyroid cancer patientsCancer patientsDichotomous outcomesLenvatinibPatientsSorafenibTreatment effectsNNTSummary measures